U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
74.50
-1.77 (-2.32%)
Jul 11, 2025, 4:00 PM - Market closed

U.S. Physical Therapy Market Cap

U.S. Physical Therapy has a market cap or net worth of $1.13 billion as of July 11, 2025. Its market cap has decreased by -21.19% in one year.

Market Cap
1.13B
Enterprise Value
1.40B
1-Year Change
-21.19%
Ranking
Category
Stock Price
$74.50

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax1 Dec 199810 Jul 2025Max ▾20002002200420062008201020122014201620182020202220240500M1,000M1,500M1,159M

Since December 1, 1998, U.S. Physical Therapy's market cap has increased from $33.40M to $1.13B, an increase of 3,288.57%. That is a compound annual growth rate of 14.15%.

History

DateMarket Cap% Change
Jul 10, 20251.16B-13.47%
Dec 31, 20241.34B-4.07%
Dec 29, 20231.40B32.50%
Dec 30, 20221.05B-14.61%
Dec 31, 20211.23B-20.16%
Dec 31, 20201.55B5.79%
Dec 31, 20191.46B12.51%
Dec 31, 20181.30B42.92%
Dec 29, 2017908.40M3.34%
Dec 30, 2016879.00M31.82%
Dec 31, 2015666.80M29.53%
Dec 31, 2014514.80M20.59%
Dec 31, 2013426.90M30.63%
Dec 31, 2012326.80M40.26%
Dec 30, 2011233.00M1.00%
Dec 31, 2010230.70M17.34%
Dec 31, 2009196.60M23.34%
Dec 31, 2008159.40M-6.24%
Dec 31, 2007170.00M20.14%
Dec 29, 2006141.50M-35.94%
Dec 30, 2005220.90M15.17%
Dec 31, 2004191.80M8.67%
Dec 31, 2003176.50M34.94%
Dec 31, 2002130.80M-22.97%
Dec 31, 2001169.80M118.25%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 714.43B
Johnson & Johnson 381.07B
AbbVie 344.57B
Novo Nordisk 308.58B
UnitedHealth Group 274.25B
Novartis AG 240.09B
Abbott Laboratories 233.35B
AstraZeneca 218.25B
Market Cap Rankings